Pemphigus Foliaceus: What You Need To Know
Rare autoimmune blistering skin disorder causing superficial erosions, crusts, and scales without mucosal involvement.
What is pemphigus foliaceus?
Pemphigus foliaceus is a rare autoimmune blistering disorder characterised by superficial blisters that rapidly evolve into erosions, crusts, and scales on the skin. Unlike pemphigus vulgaris, it spares mucous membranes and affects only the superficial epidermis due to autoantibodies targeting desmoglein 1, a desmosomal protein responsible for keratinocyte adhesion in the granular layer. This results in acantholysis—loss of cell-to-cell cohesion—leading to fragile bullae that rupture easily, producing characteristic flaky, leaf-like (foliaceus) scales.
The condition is less severe than pemphigus vulgaris, often localised to seborrhoeic areas like the face, scalp, upper trunk, and flexures. It can be sporadic, drug-induced, or endemic, as in fogo selvagem in South America. Incidence is low, around 1-2 cases per million annually worldwide, but higher in endemic regions. Spontaneous remission occurs in some cases, while others experience chronic, relapsing disease lasting years.
Who gets pemphigus foliaceus?
Pemphigus foliaceus typically affects middle-aged to older adults, with peak onset between 50-60 years, though it can occur at any age. It shows no strong gender preference but has genetic associations, particularly in Ashkenazi Jewish populations for related pemphigus forms. Endemic forms target younger individuals in rural Brazil and Colombia.
- Sporadic pemphigus foliaceus: Middle-aged adults, often fair-skinned individuals in temperate climates.
- Drug-induced: Associated with medications like penicillamine, ACE inhibitors (captopril, enalapril), calcium channel blockers (nifedipine), NSAIDs, and antibiotics (penicillin, rifampicin).
- Endemic (fogo selvagem): Children and young adults in specific South American regions, linked to environmental triggers like insect bites and genetic HLA-DR4/DRB1 alleles.
Risk factors include family history, UV exposure, and insect bites in endemic areas.
What causes pemphigus foliaceus?
The primary cause is autoimmune: IgG autoantibodies against desmoglein 1 (Dsg1) disrupt desmosomes in the superficial epidermis, causing acantholysis. Triggers include:
- Genetic predisposition: HLA associations, especially in endemic forms.
- Environmental factors: UV light provokes flares; insect vectors suspected in fogo selvagem.
- Drugs: Thiol drugs (penicillamine) and others induce 50% remission upon withdrawal.
- Infections: Possible viral or blackfly (Simulium nigrimanum) role in endemic cases.
Pathogenesis involves loss of tolerance to Dsg1, with superficial cleavage distinguishing it from deep-split pemphigus vulgaris.
What are the clinical features of pemphigus foliaceus?
Initial lesions are transient, flaccid vesicles or bullae in seborrhoeic distribution (scalp, face, upper chest, back). They rupture easily, forming erosions covered by golden-yellow, greasy crusts and scales that extend peripherally (‘cornflake’ appearance).
- Pruritus: Mild to intense itching common.
- Erosions and scales: Erythematous, healing with post-inflammatory hyperpigmentation.
- Distribution: Central face (malar), scalp (resembling seborrhoeic dermatitis), intertriginous areas; rarely generalised.
- Nails: Occasional paronychia or nail dystrophy.
- Mucosa: Spared, unlike pemphigus vulgaris.
Severe cases may show exfoliative erythroderma. Secondary infection causes pain, pustules. Flares triggered by sun, stress, drugs.
Diagnosis of pemphigus foliaceus
Clinical suspicion confirmed by:
- Skin biopsy: Suprabasal acantholysis, ‘row of tombstones’ appearance, superficial cleft.
- Direct immunofluorescence (DIF): Intercellular IgG/C3 deposition (‘fishnet’ pattern) on epidermis.
- Serum ELISA: Anti-Dsg1 antibodies elevated; anti-Dsg3 negative.
Differential includes impetigo, seborrhoeic dermatitis, lupus, Hailey-Hailey disease.
Treatment of pemphigus foliaceus
Treatment aims to suppress autoantibody production and promote healing. Mild cases respond to topicals; severe require systemic therapy.
| Severity | Treatment | Dosage/Notes |
|---|---|---|
| Mild/localised | High-potency topical corticosteroids (e.g., clobetasol) | ± calcineurin inhibitors (tacrolimus); antibiotics for infection |
| Moderate/severe | Systemic corticosteroids (prednisone/prednisolone) | 0.5-1.5 mg/kg/day, taper slowly |
| Steroid-sparing | Azathioprine, mycophenolate mofetil (MMF) | 1-3 mg/kg/day; 2g/day MMF (onset 2-12 months) |
| Refractory | Rituximab, IVIG, dapsone, hydroxychloroquine, MTX, plasma exchange | Rituximab: effective in 80-90% |
First-line: topical steroids for limited disease. Systemic prednisone for extensive cases, combined with immunosuppressants to minimise steroid side effects (osteoporosis, diabetes). Monitor for infections; antifungals/antibiotics as needed. Remission possible, but relapses common.
What is the outcome for pemphigus foliaceus?
Prognosis excellent; milder than vulgaris with low mortality (<5%). Many achieve remission with treatment; 30-50% spontaneous resolution in drug-induced. Chronic cases managed long-term. Complications: steroid side effects, infections. Regular follow-up essential.
Images
(Description: Clinical images show scaly erythematous plaques on malar cheeks, flaking scalp lesions, and crusted erosions on trunk resembling cornflakes.)
Frequently Asked Questions
Q: Is pemphigus foliaceus contagious?
A: No, it is an autoimmune condition, not infectious.
Q: Can pemphigus foliaceus be cured?
A: Not always cured, but often controlled; remission possible.
Q: Does sun exposure worsen it?
A: Yes, UV light triggers flares; use sunscreen.
Q: What if I suspect pemphigus foliaceus?
A: See a dermatologist for biopsy and immunofluorescence.
Q: Are there dietary restrictions?
A: No specific; avoid triggers like certain drugs.
References
- Pemphigus Foliaceus: Causes, Symptoms and Images — DermNet NZ. 2025. https://dermnetnz.org/topics/pemphigus-foliaceus
- Pemphigus Foliaceus — MD Searchlight. 2024. https://mdsearchlight.com/skin-problems-and-treatments/pemphigus-foliaceus/
- Pemphigus Foliaceus: Symptoms, Causes, Treatment & More — Healthline. 2024. https://www.healthline.com/health/pemphigus-foliaceus
- Pemphigus Foliaceus — MSD Manuals Professional Edition. 2026. https://www.msdmanuals.com/professional/dermatologic-disorders/bullous-diseases/pemphigus-foliaceus
- Pemphigus foliaceus: A rare blistering skin lesion — European Journal of General Medicine. 2023-01-01. https://www.ejgm.co.uk/download/pemphigus-foliaceus-a-rare-blistering-skin-lesion-12831.pdf
Similar Articles
Read full bio of Sneha Tete
